$24.7 Thousand is the total value of TLS Advisors LLC's 15 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 13.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EQT | EQT CORP | $6,097 | -1.0% | 150,800 | 0.0% | 24.66% | -6.6% | |
| OVID | OVID THERAPEUTICS INC | $5,068 | +17.1% | 1,319,679 | 0.0% | 20.50% | +10.4% | |
| FB | META PLATFORMS INC-CLASS A | $3,179 | +4.6% | 10,589 | 0.0% | 12.86% | -1.4% | |
| VALE | Buy | VALE SA-SP ADR | $1,769 | +61.7% | 132,000 | +57.1% | 7.16% | +52.5% |
| XOMA | XOMA CORP | $1,700 | -25.4% | 120,665 | 0.0% | 6.88% | -29.7% | |
| RRC | Sell | RANGE RESOURCES CORP | $1,553 | -10.0% | 47,923 | -18.5% | 6.28% | -15.1% |
| OMNIAB INC | $1,298 | +3.2% | 250,185 | 0.0% | 5.25% | -2.7% | ||
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,126 | -13.4% | 32,956 | -2.4% | 4.56% | -18.3% |
| BHP | Buy | BHP GROUP LTD-SPON ADR | $1,049 | +34.5% | 18,440 | +37.2% | 4.24% | +26.8% |
| RIO | Buy | RIO TINTO PLC-SPON ADR | $1,031 | +48.3% | 16,200 | +44.6% | 4.17% | +39.9% |
| HOV | HOVNANIAN ENTERPRISES-A | $393 | +2.3% | 3,872 | 0.0% | 1.59% | -3.5% | |
| EWS | ISHARES MSCI SINGAPORE ETF | $250 | -0.8% | 13,600 | 0.0% | 1.01% | -6.5% | |
| REGN | New | REGENERON PHARMACEUTICALS | $205 | – | 250 | +100.0% | 0.83% | – |
| NEAR INTELLIGENCE INC | $1 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% | ||
| YNDX | YANDEX NV-A | $1 | 0.0% | 17,811 | 0.0% | 0.00% | 0.0% | |
| GTEC | Exit | GREENLAND TECHNOLOGIES HOLDI | $0 | – | -12,054 | -100.0% | -0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQT CORPORATION | 4 | Q3 2023 | 26.4% |
| OVID THERAPEUTICS INC | 4 | Q3 2023 | 20.5% |
| META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK | 4 | Q3 2023 | 13.0% |
| XOMA CORP COM | 4 | Q3 2023 | 13.1% |
| OMNIAB INC REG SHS COM | 4 | Q3 2023 | 6.9% |
| XENON PHARMACEUTICALS INC SHS | 4 | Q3 2023 | 6.6% |
| RANGE RESOURCES CORP | 4 | Q3 2023 | 8.1% |
| HOVNANIAN ENTERPRISES INC COM | 4 | Q3 2023 | 1.6% |
| ISHARES MSCI SINGAPORE ETF | 4 | Q3 2023 | 1.4% |
| YANDEX NV-A | 4 | Q3 2023 | 1.7% |
View TLS Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ovid Therapeutics Inc. | May 27, 2020 | 2,489,415 | 4.6% |
View TLS Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2020-05-27 |
| SC 13D/A | 2019-11-27 |
| SC 13D/A | 2019-10-07 |
| SC 13D | 2019-03-01 |
View TLS Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.